Rabson–Mendenhall syndrome
ICD-10: E13ORPHA: 769
Overview
medical condition
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with Rabson–Mendenhall syndrome, sourced from HPO and Orphanet clinical annotations.
Reduced subcutaneous adipose tissueShort statureFasting hyperinsulinemiaClitoral hypertrophySevere postnatal growth retardationPostprandial hyperglycemiaOnychauxisHypertrichosisHirsutismIntellectual disabilityGlobal developmental delayIntrauterine growth retardationRecurrent infectionsFasting hypoglycemiaLong penisAbnormality of the dentitionDental crowdingInsulin-resistant diabetes mellitusInsulin resistanceAcanthosis nigricansDry skinIncreased serum testosterone levelIncreased circulating androgen concentrationIncreased C-peptide levelLichenoid skin lesionThick hairEnlarged ovariesNephrocalcinosisMacroglossiaGingival overgrowthHigh palateFurrowed tongueCoarse facial featuresLow anterior hairlineMandibular prognathiaMacrotiaProminent nasal bridgeWide noseAnteverted naresRetinopathyHypothyroidismPrecocious pubertyVentricular septal defectAtrial septal defectCardiomyopathyDiabetic ketoacidosisPolydipsiaPremature graying of hairDelayed skeletal maturationHypokalemiaAdvanced eruption of teethCNS demyelinationPeripheral neuropathyPolydactylyIncreased pineal volumeImpaired glucose tolerance
Classification & Codes
ICD-10 Code
E13Orphanet Code
ORPHA:769Rabson–Mendenhall syndrome
| ICD-10 | E13 |
| Orphanet | ORPHA:769 |
| Treatments | 0 drug(s) |
| Symptoms on record | 56 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO